Edition:
India

Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

3.53CAD
10:18pm IST
Change (% chg)

$0.05 (+1.44%)
Prev Close
$3.48
Open
$3.50
Day's High
$3.55
Day's Low
$3.50
Volume
125,724
Avg. Vol
47,208
52-wk High
$4.31
52-wk Low
$1.11

Chart for

About

Resverlogix Corp is Canada-based clinical-stage biotechnology company. The Company is developing apabetalone (RVX-208), a molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is the BET inhibitor... (more)

Overall

Beta: 3.51
Market Cap(Mil.): $206.99
Shares Outstanding(Mil.): 114.62
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates